Recrutamento encerrado
FASE
Número Europeu 2013-003133-14
LUZ11-CDU-001
An Open-label Study to Investigate the Tolerability, Pharmacokinetics and Anti-tumour Effect Following Photodynamic Therapy (PDT) With Single-ascending Doses of LUZ11 in Patients With Advanced Head and Neck Cancer
Detalhes
Destaques